stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.48
0.53
+1.02%
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) Shares outstanding
Heartflow, Inc.'s shares outstanding at the end of fiscal 2025 was $36.9M, up 587.1% from $5.4M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $86.4M. Heartflow, Inc. ranks 14th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $36.9M | 587.14% |
| FY2024 | $5.4M | 9.79% |
| FY2023 | $4.9M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $86.4M | 0.89% |
| Mar 2026 | $85.6M | 132.38% |
| Dec 2025 | $36.9M | (24.95%) |
| Sep 2025 | $49.1M | 677.46% |
| 6 more quarters | Free account |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| WAY Waystar Holding Corp. compare | $195.9M |
| DOCS Doximity, Inc. compare | $187.8M |
| TDOC Teladoc Health, Inc. compare | $181.9M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. | $86.4M |
| HQY HealthEquity, Inc. compare | $84.0M |
| HNGE Hinge Health Inc. compare | $83.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
| OMCL Omnicell, Inc. compare | $46.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on HTFL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Book value per share
- The full statement